Bořivoj Vojtěšek

13.7k total citations · 1 hit paper
314 papers, 10.8k citations indexed

About

Bořivoj Vojtěšek is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bořivoj Vojtěšek has authored 314 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Molecular Biology, 153 papers in Oncology and 52 papers in Cell Biology. Recurrent topics in Bořivoj Vojtěšek's work include Cancer-related Molecular Pathways (125 papers), Cancer Research and Treatments (48 papers) and Ubiquitin and proteasome pathways (31 papers). Bořivoj Vojtěšek is often cited by papers focused on Cancer-related Molecular Pathways (125 papers), Cancer Research and Treatments (48 papers) and Ubiquitin and proteasome pathways (31 papers). Bořivoj Vojtěšek collaborates with scholars based in Czechia, United Kingdom and Poland. Bořivoj Vojtěšek's co-authors include David P. Lane, Roman Hrstka, Jiří Bártek, Petr Müller, Philip J. Coates, Carol Midgley, Jan Kovařík, Ted R. Hupp, Rudolf Nenutil and Jiřina Bártková and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Bořivoj Vojtěšek

297 papers receiving 10.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An immunochemical analysis of the human nuclear phosphoprotein p53

1992 503 citations Bořivoj Vojtěšek, David P. Lane et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bořivoj Vojtěšek Czechia	53	6.4k	5.0k	1.7k	1.2k	1.1k	314	10.8k
Christopher M. Counter United States	53	10.1k 1.6×	3.2k 0.6×	1.6k 0.9×	1.1k 0.8×	796 0.7×	117	16.2k
Maureen E. Murphy United States	54	8.4k 1.3×	5.4k 1.1×	2.4k 1.4×	1.1k 0.9×	1.2k 1.1×	143	12.8k
Giannino Del Sal Italy	61	10.4k 1.6×	5.5k 1.1×	2.3k 1.3×	2.3k 1.9×	830 0.7×	136	14.1k
Toshiyuki Miyashita Japan	46	10.1k 1.6×	5.7k 1.1×	1.9k 1.1×	787 0.6×	764 0.7×	123	14.1k
Kristoffer Valerie United States	60	6.4k 1.0×	3.9k 0.8×	1.6k 0.9×	728 0.6×	704 0.6×	164	10.4k
Akira Nakagawara Japan	69	11.4k 1.8×	5.3k 1.1×	4.4k 2.5×	1.6k 1.2×	1.3k 1.2×	347	18.0k
Lewis A. Chodosh United States	61	9.6k 1.5×	4.4k 0.9×	3.1k 1.8×	1.3k 1.0×	600 0.5×	153	14.4k
Jer‐Tsong Hsieh United States	63	7.5k 1.2×	3.4k 0.7×	2.3k 1.3×	954 0.8×	540 0.5×	267	12.9k
Douglas E. Brash United States	44	5.7k 0.9×	2.9k 0.6×	1.6k 0.9×	1.1k 0.9×	1.5k 1.4×	96	10.3k
Takashi Tokino Japan	62	12.8k 2.0×	6.5k 1.3×	3.8k 2.2×	1.0k 0.8×	1.2k 1.1×	227	17.4k

Countries citing papers authored by Bořivoj Vojtěšek

Since Specialization

Citations

This map shows the geographic impact of Bořivoj Vojtěšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bořivoj Vojtěšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bořivoj Vojtěšek more than expected).

Fields of papers citing papers by Bořivoj Vojtěšek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bořivoj Vojtěšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bořivoj Vojtěšek. The network helps show where Bořivoj Vojtěšek may publish in the future.

Co-authorship network of co-authors of Bořivoj Vojtěšek

This figure shows the co-authorship network connecting the top 25 collaborators of Bořivoj Vojtěšek. A scholar is included among the top collaborators of Bořivoj Vojtěšek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bořivoj Vojtěšek. Bořivoj Vojtěšek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benešová, Iva, Rudolf Nenutil, Erika Lattová, et al.. (2024). N-glycan profiling of tissue samples to aid breast cancer subtyping. Scientific Reports. 14(1). 320–320. 9 indexed citations

Hupp, Ted R., et al.. (2024). Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis. Cellular & Molecular Biology Letters. 29(1). 117–117. 3 indexed citations

Faktor, Jakub, Lenka Hernychová, A. Jonathan Singh, et al.. (2024). Metaproteomic analysis from cervical biopsies and cytologies identifies proteinaceous biomarkers representing both human and microbial species. Talanta. 278. 126460–126460. 1 indexed citations

Kokáš, Filip, et al.. (2024). TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer. Scientific Reports. 14(1). 29949–29949.

Hollá, Lýdie Izakovičová, et al.. (2020). Tooth agenesis: What do we know and is there a connection to cancer?. Clinical Genetics. 99(4). 493–502. 26 indexed citations

Liu, Yajing, Marta Nekulová, Rudolf Nenutil, et al.. (2019). ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem‐like cells in human ER⁺ and HER2⁺ breast cancers. The Journal of Pathology Clinical Research. 6(1). 83–93. 15 indexed citations

O’Neill, J. Robert, HuiSong Pak, Erola Pairo‐Castineira, et al.. (2017). Quantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins. Molecular & Cellular Proteomics. 16(6). 1138–1150. 16 indexed citations

Fielding, Ceri A., Michael P. Weekes, Luís Nobre, et al.. (2017). Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation. eLife. 6. 56 indexed citations

Obacz, Joanna, Veronika Brychtová, Pavel Fabián, et al.. (2015). Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients. SHILAP Revista de lepidopterología. 1 indexed citations

10.

Bouchal, Pavel, Monika Dvořáková, Theodoros I. Roumeliotis, et al.. (2015). Combined Proteomics and Transcriptomics IdentifiesCarboxypeptidase B1 and Nuclear Factor kappa B (NF-kappa B)Associated Proteins as Putative Biomarkers of Metastasis in LowGrade Breast Cancer. Molecular & Cellular Proteomics. 2 indexed citations

11.

Hrstka, Roman, et al.. (2014). Second Primary Cancers – Causes, Incidence and the Future. Klinicka onkologie. 27(1). 11–17. 22 indexed citations

12.

Mondal, Abdul M., Izumi Horikawa, Sharon R. Pine, et al.. (2013). p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. Journal of Clinical Investigation. 123(12). 5247–5257. 123 indexed citations

13.

Bouchal, Pavel, Jiří Jarkovský, Kristýna Hrazdilová, et al.. (2011). The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo. Proteome Science. 9(1). 68–68. 18 indexed citations

14.

Fraser, Jennifer A., Bořivoj Vojtěšek, & Ted R. Hupp. (2010). A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal. Journal of Biological Chemistry. 285(48). 37762–37772. 25 indexed citations

15.

Knížek, Jiří, et al.. (2008). Test of the Hypothesis That One Group of Dependences is Consistent with Another Group of Dependences. 2(1-2). 2–15. 1 indexed citations

16.

Avery‐Kiejda, Kelly A., Xu Dong Zhang, Rodney J. Scott, et al.. (2008). Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin. Clinical Cancer Research. 14(6). 1659–1668. 107 indexed citations

17.

Hrstka, Roman, Philip J. Coates, & Bořivoj Vojtěšek. (2008). Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment. Journal of Cellular and Molecular Medicine. 13(3). 440–453. 55 indexed citations

18.

Brázda, Václav, et al.. (2006). Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity. Biochemical and Biophysical Research Communications. 351(2). 499–506. 24 indexed citations

19.

Paleček, Emil, Veronika Staňková, Václav Brázda, et al.. (1997). Tumor suppressor protein p53 binds preferentially to supercoiled DNA. Oncogene. 15(18). 2201–2209. 74 indexed citations

20.

Vojtěšek, Bořivoj, et al.. (1995). Absence of p53 autoantibodies in a significant proportion of breast cancer patients. British Journal of Cancer. 71(6). 1253–1256. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact